Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Herbert

Showing results (561-570 of 657) with videos related to

Pageof 66
Sort By:
AIDS (London, England)|February 1, 1994
Risk behaviour and HIV prevalence in international travellersS Hawkes, G J Hart, A M Johnson, et al.
Journal of Medicinal Chemistry|October 28, 1997
New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agentA Badorc, M F Bordes, P de Cointet, et al.
Thrombosis Research|November 26, 1999
Laboratory monitoring of pentasaccharide in a dog model of hemodialysisD A Hoppensteadt, W P Jeske, J M Walenga, et al.
Journal of Applied Microbiology|October 24, 2007
A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccineS Charlton, M Herbert, J McGlashan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 5, 2014
Chronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscleDanielle R Plomaritas, Lindsay M Herbert, Tracylyn R Yellowhair, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodiesS Ahmad, W P Jeske, J M Walenga, et al.
Biochimie|May 27, 2003
Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparinEugen Sisu, Sasmita Tripathy, Jean-M Mallet, et al.
Wiley Interdisciplinary Reviews. Computational Molecular Science|December 15, 2025
Fragme∩t: An Open-Source Framework for Multiscale Quantum Chemistry Based on FragmentationDustin R Broderick, Paige E Bowling, Chance Brandt, et al.
FEMS Microbiology Letters|August 1, 1996
Purification and characterization of a novel protease from culture filtrates of a Streptomyces spF Bono, P Savi, A Tuong, et al.
Circulation Research|September 1, 1996
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparinJ M Herbert, J P Hérault, A Bernat, et al.
Pageof 66

Showing results (561-570 of 657) with videos related to

Sort By:
Pageof 66
AIDS (London, England)|February 1, 1994
Risk behaviour and HIV prevalence in international travellersS Hawkes, G J Hart, A M Johnson, et al.
Journal of Medicinal Chemistry|October 28, 1997
New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agentA Badorc, M F Bordes, P de Cointet, et al.
Thrombosis Research|November 26, 1999
Laboratory monitoring of pentasaccharide in a dog model of hemodialysisD A Hoppensteadt, W P Jeske, J M Walenga, et al.
Journal of Applied Microbiology|October 24, 2007
A study of the physiology of Bacillus anthracis Sterne during manufacture of the UK acellular anthrax vaccineS Charlton, M Herbert, J McGlashan, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|July 5, 2014
Chronic hypoxia limits H2O2-induced inhibition of ASIC1-dependent store-operated calcium entry in pulmonary arterial smooth muscleDanielle R Plomaritas, Lindsay M Herbert, Tracylyn R Yellowhair, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodiesS Ahmad, W P Jeske, J M Walenga, et al.
Biochimie|May 27, 2003
Synthesis of new conformationally constrained pentasaccharides as molecular probes to investigate the biological activity of heparinEugen Sisu, Sasmita Tripathy, Jean-M Mallet, et al.
Wiley Interdisciplinary Reviews. Computational Molecular Science|December 15, 2025
Fragme∩t: An Open-Source Framework for Multiscale Quantum Chemistry Based on FragmentationDustin R Broderick, Paige E Bowling, Chance Brandt, et al.
FEMS Microbiology Letters|August 1, 1996
Purification and characterization of a novel protease from culture filtrates of a Streptomyces spF Bono, P Savi, A Tuong, et al.
Circulation Research|September 1, 1996
Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparinJ M Herbert, J P Hérault, A Bernat, et al.
Pageof 66